Pfizer
Delta-specific vaccine could be ready in time for winter booster campaign
Pfizer will begin clinical trials next month for an altered version of its Covid jab that targets full spike protein of variant
Sunday Interview: Paul Reid of Pfizer Healthcare Ireland
The country manager on the development of the pioneering vaccine and why Ireland will not be used as a manufacturing base for it in the short term
Comment: Vaccination numbers don’t add up – we’ll be living and dying with Covid-19 until 2022
Ireland needs to be vaccinating upwards of 100,000 people a week but we show no signs of getting close to that figure
Pfizer vaccine approved by EMA
Ireland to receive 5,000 doses by the end of the year, nursing home residents over 65 first in line to be vaccinated
BioNtech in bid to increase vaccine production by 750 million doses a year
Covid-19 vaccine co-manufacturer buys new manufacturing plant from Novartis in Germany to ramp up production
Vaccine trials were run to the highest regulatory standards says Icon drug trials leader
Dr Nuala Murphy, president of clinical research at the Dublin HQ of drug testing giant Icon says she will be ‘absolutely’ taking the Pfizer/BioNtech vaccine
